Articles
-
New Schaeffer Center White Paper Explains Complicated Relationship Between FDA Approvals and Future Innovation
The relationship between approvals and future innovation is unclear at best. As such, the FDA should continue to base its decisions solely on safety and efficacy, rather than speculative long-term innovation effects.
Categorized in -
Roybal Fellow Sparks Winning Nudge to Increase Vaccine Uptake
Jehan Sparks helped design the top-performing “nudge” which resulted in an 11% increase in the rate of flu shot vaccinations.
-
Targeted Therapies Linked to Improved Outcomes for Advanced-Stage Breast Cancer Patients
Targeted therapies accounted for about 90% of new active substance approvals in oncology between 2011 and 2018.
Categorized in -
‘Pharmacy Deserts’ Disproportionately Affect Black and Latino Residents in Largest U.S. Cities
Black and Latino neighborhoods in the 30 most populous U.S. cities had fewer pharmacies than white or diverse neighborhoods in 2007-2015, USC research shows, suggesting that ‘pharmacy deserts’ — like so-called food deserts — may be an overlooked contributor to persistent racial and ethnic health disparities.
Categorized in -
California Native Americans Won Healthcare Settlement. Federal Government Hasn’t Delivered
Despite a 1979 federal court-ordered settlement that would have pumped millions of dollars into California for Native American health care, the state’s share remains stunningly underfunded by the Indian Health Service, according to a new story from The Center for Health Reporting.
Categorized in -
Don’t Make Surgery Another COVID Casualty
Investing in minimally invasive tools can free up valuable beds when pandemic surges threaten to overwhelm hospitals, argues Van Nuys and Lakdawalla in MedPage Today.
Categorized in -
We Can’t Have Everything: The Role of Payment for Volume and Choice of Providers in Fueling Health Care Expenditures
Victor Fuchs outlines several health policy reforms to control health care expenditures.
Categorized in -
Podcast: The Impact and Economics of Alzheimer’s
Julie Zissimopoulos recently spoke about her research using economic insights to better understand the impact of Alzheimer’s disease on individuals, families, caregivers, and society.
-
Insurer Formularies Complicate the Adoption of Biosimilar Cancer Therapies
A new blog post coauthored by Schaeffer Center experts in Health Affairs finds that insurer preferences for biologic and biosimilar drugs adds cost and complicates the work of hospital pharmacists and physicians.
Categorized in -
Rapid COVID Tests Used Twice Weekly Could Detect Most Contagious School-Aged Kids
While COVID-19 hospitalizations are down, a new Schaeffer Center white paper highlights the importance of investing in minimally invasive technologies that will allow hospitals to prepare for future surges.
Categorized in